Back to Blog
•1 min readUpdated Aug 4, 2025
Aurobindo Pharma Q1 Results: Profit Falls 10%, Misses Estimates
According to the press release, the pharma company's US formulations revenue marginally declined by 1.9% year-on-year to Rs 3,488 crore, while the Europe formul...
Aurobindo Pharma Ltd.'s profit declined 10% in the first quarter of this financial year. The drugmaker has posted a consolidated bottom line of Rs 825 crore, according to the financial results declared on Monday. This is in comparison to the profit of Rs 919 crore in the same quarter of the previous fiscal year. Revenue increased by 4% year-on-year for the three months ended June, reaching Rs 7,868 crore. Operating income fell 1% year-on-year